Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 19, 2021 (Week 24)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2021 †Cum YTD 2020 †Current weekPrevious 52 weeks Max †Cum YTD 2021 †Cum YTD 2020 †
U.S. Residents, excluding U.S. Territories 66 180 2,974 7,337 - 7 56 117
New England 3 18 135 455 - 1 - 4
Connecticut - 5 24 116 - 0 - 1
Maine 1 9 34 57 - 0 - -
Massachusetts 2 5 52 179 - 1 - -
New Hampshire - 3 14 51 - 0 - 2
Rhode Island - 3 9 31 - 0 - -
Vermont - 1 2 21 - 1 - 1
Middle Atlantic 15 33 358 1,005 - 6 25 36
New Jersey 3 11 68 290 - 3 15 24
New York (excluding New York City) 6 19 149 294 - 1 3 8
New York City 6 14 141 342 - 6 7 1
Pennsylvania - 4 - 79 - 1 - 3
East North Central - 33 565 1,383 - 2 9 31
Illinois N NC N N N NC N N
Indiana - 14 129 264 - 1 - -
Michigan - 10 103 347 - 1 2 1
Ohio - 19 248 573 - 1 7 30
Wisconsin - 8 85 199 - 0 - -
West North Central 2 10 53 402 - 1 - 7
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 1 - - - 0 - -
Missouri - 7 12 263 - 1 - 5
Nebraska 1 4 26 71 - 0 - 2
North Dakota 1 3 15 37 - 1 - -
South Dakota - 1 - 31 - 0 - -
South Atlantic 16 37 613 1,210 - 2 8 13
Delaware - 3 20 41 - 0 - -
District of Columbia - 2 8 40 - 0 - -
Florida 11 24 251 388 - 2 5 7
Georgia 4 16 188 316 - 0 - -
Maryland 1 7 84 212 - 1 2 -
North Carolina N NC N N N NC N N
South Carolina - 6 7 77 - 1 1 3
Virginia - 1 6 7 - 0 - -
West Virginia - 8 49 129 - 0 - 3
East South Central 1 27 368 788 - 1 2 4
Alabama - 10 103 181 - 0 - -
Kentucky - 4 43 169 - 1 2 2
Mississippi 1 6 59 122 - 0 - -
Tennessee - 15 163 316 - 0 - 2
West South Central 12 38 303 827 - 3 7 14
Arkansas 2 10 53 137 - 1 - 1
Louisiana - 13 115 178 - 1 - 3
Oklahoma N NC N N N NC N N
Texas 10 29 135 512 - 3 7 10
Mountain 17 45 516 1,152 - 2 5 3
Arizona 13 37 292 430 - 2 2 1
Colorado - 12 - 226 - 0 - -
Idaho N NC N N N NC N N
Montana - 3 25 53 - 0 - 2
Nevada - 8 59 180 - 0 - -
New Mexico 4 7 71 138 - 0 - -
Utah - 9 58 108 - 1 3 -
Wyoming - 3 11 17 - 0 - -
Pacific - 10 63 115 - 1 - 5
Alaska - 10 53 85 - 1 - 5
California N NC N N N NC N N
Hawaii - 2 10 30 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - - - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - - - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 66 180 2,974 7,337 - 7 56 117
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.